Dicerna’s best hope for nedosiran use likely in non-responders to Alnylam’s Oxlumo in primary hyperoxaluria type 1

Dicerna
Nedosiran’s differentiated mechanism compared to Oxlumo allows it to be applicable to PH type 2 and PH type 3. Credit: Tareq Salahuddin.